Detection of Hypovolemia in the Elderly Patient Undergoing Surgery (HOOI)

January 26, 2024 updated by: Carolien SE Bulte, Amsterdam UMC, location VUmc

Prospective observational study, in which the primary aim of the study is to determine the incidence of perioperative hypovolemia in the elderly patient scheduled for major surgery. Hypovolemia is defined as the presence of fluid responsiveness, which equals increase in stroke volume > 10% after a passive leg raise according to the Nexfin non-invasive cardiac output measurement.

This study aims to include 150 elderly patients aging 70 years or older undergoing scheduled major surgery. The passive leg raising test on 4 consecutive time points in the perioperative period.

Study Overview

Detailed Description

Rationale:

There is currently limited evidence available on the occurrence of perioperative hypovolemia in the elderly population, and whether this hypovolemic state is related to postoperative complications in these patients. More information regarding this relationship may be valuable in strategies aiming for a reduction in postoperative complications in the elderly. In particular, postoperative complications lead to long term morbidity, decrease quality of live, increase health care costs and are the most important factor of patient survival. Therefore, the present study aims to investigate how many elderly patients suffer from hypovolemia in the perioperative period, and how this relates to postoperative complications.

Objective:

The primary aim of the study is to determine the incidence of perioperative hypovolemia in the elderly patient scheduled for major surgery. Hypovolemia is defined as the presence of fluid responsiveness, which equals increase in stroke volume > 10% after a passive leg raise according to the Nexfin non-invasive cardiac output measurement.

Study design:

Open, prospective, observational study

Study population:

150 elderly patients aging 70 years or older undergoing scheduled major surgery.

Intervention:

Passive leg raising test on 4 consecutive time points in the perioperative period

Main study endpoints:

Relative number of patients that have a change in stroke volume of more than 10% upon a passive leg raising test.

Nature and extent of the burden and risks associated with participation, benefit and group relatedness:

One of the investigators will visit the ward and will use the inflatable blood pressure cuff around the index finger of the right hand. The measurement will be performed while sitting and is continued for 5 minutes after lowering the head end of the bed and raising the lower end of the bed. As the bed functions electronical the change in movement occurs slowly and without any effort. Overall discomfort associated with these tests is regarded to as minimal. There are no benefits related to participation.

Study Type

Observational

Enrollment (Actual)

143

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Noord-Holland
      • Amsterdam, Noord-Holland, Netherlands, 1081HV
        • Amsterdam UMC, location VUmc

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

150 elderly patients aging 70 years or older admitted to the hospital for scheduled major surgery. Major surgery will be defined as an expected length of stay being at least two postoperative days as these carry the greatest complication risk, including gastro-intestinal, pulmonary, major gynecological or urological and vascular surgery.

Description

Inclusion Criteria:

  • Informed consent
  • Age 70 years or older
  • Scheduled for elective surgery
  • Procedures with expected postoperative stay of at least two days

Exclusion Criteria:

  • Procedure in ambulatory practice
  • Acute surgery
  • Patients with current cardiac arrhythmias
  • Symptoms of cardiovascular shock or decompensation at presentation
  • Impossible to perform measurements due to patient characteristics
  • Inability to comprehend patient information and consequences of the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Elderly perioperative population
All patients included in the study (minimum 70 years of age on day of surgery)

Stroke volume measurements are performed with the Nexfin hemodynamic monitor and the volemic state measurement is based on the principle of the classic passive leg raise test. The Nexfin monitor (Nexfin CC, Edwards Life Sciences, the Netherlands) uses a small inflatable cuff around the index finger of the right hand, to measure the blood pressure, and uses a specific algorithm to calculate the stroke volume.

First a baseline measurement is performed during supine position while the patient is lying in bed. Next, the head end will be lowered until lying flat, and the legs will be passively raised until the lower end of the bed is 30 degrees elevated. The change in stroke volume following the passive leg raise test is used to assess fluid responsiveness. An increase of 10% indicates a fluid responsive status or hypovolemia.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of hypovolemia (%)
Time Frame: Preoperatively; and postoperatively (at 2, 24 and 48 hours postoperatively)
preoperative incidence of hypovolemia (stroke volume increase of 10% or more upon a passive leg raising manoeuvre)
Preoperatively; and postoperatively (at 2, 24 and 48 hours postoperatively)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postoperative complications
Time Frame: 30 day
All complications (descriptive); classified conform Clavien-Dindo classification
30 day
Postoperative mortality
Time Frame: 30 day
mortality
30 day
Postoperative care
Time Frame: 30 day
Unplanned Intensive Care Unit admission (categorical: yes/no); and if applicable for how long (continuous; in days).
30 day
Blood transfusion
Time Frame: intra-operative (duration of surgical procedure)
Erythrocytes concentrate transfusion (continuous scale; number of units)
intra-operative (duration of surgical procedure)
Fluid administration
Time Frame: intra-operative (duration of surgical procedure)
All fluids administered: including crystalloids, colloids, medication, all blood product (continuous scale, in mL)
intra-operative (duration of surgical procedure)
Vaso-active therapy
Time Frame: intra-operative (duration of surgical procedure)
Use of vaso active medication, including norepinephrine; epinephrine; dobutamine; atropine; phenylephrine; ephedrine (categorical: yes/no).
intra-operative (duration of surgical procedure)
Duration of surgery
Time Frame: intra-operative (duration of surgical procedure)
Duration of surgical procedure (continuous scale; in minutes)
intra-operative (duration of surgical procedure)
Anesthetic technique
Time Frame: intra-operative (duration of surgical procedure)
Type of anesthesia (nominal categories; general anesthesia; spinal; epidural; or mixed)
intra-operative (duration of surgical procedure)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Carolien Bulte, Phd, Amsterdam UMC, location VUmc

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2018

Primary Completion (Actual)

May 1, 2020

Study Completion (Actual)

November 25, 2021

Study Registration Dates

First Submitted

August 14, 2023

First Submitted That Met QC Criteria

January 26, 2024

First Posted (Estimated)

January 29, 2024

Study Record Updates

Last Update Posted (Estimated)

January 29, 2024

Last Update Submitted That Met QC Criteria

January 26, 2024

Last Verified

January 1, 2024

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • ABR NL62141.029.17
  • METC 2018.009 (Other Identifier: Ethics Committee VUmc)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hypovolemia

Clinical Trials on Passive leg raise manoeuvre

Subscribe